{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:08:15Z","timestamp":1772093295555,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ophtha.2007.03.007","type":"journal-article","created":{"date-parts":[[2008,1,12]],"date-time":"2008-01-12T07:20:42Z","timestamp":1200122442000},"page":"99-103.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Comparison of the 24-Hour Intraocular Pressure\u2013Lowering Effects of Latanoprost and Dorzolamide\/Timolol Fixed Combination after 2 and 6 Months of Treatment"],"prefix":"10.1016","volume":"115","author":[{"given":"Anastasios G.P.","family":"Konstas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios P.","family":"Kozobolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevasti","family":"Tsironi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Makridaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rallitsa","family":"Efremova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2007.03.007_bib1","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.007_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.007_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","article-title":"A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension","volume":"103","author":"Watson","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.007_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1600-0420.1999.770214.x","article-title":"The use of latanoprost 0.005% once daily to simplify medical therapy in patients with primary open-angle glaucoma or ocular hypertension","volume":"77","author":"Smith","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"issue":"suppl","key":"10.1016\/j.ophtha.2007.03.007_bib5","first-page":"17","article-title":"A randomized trial in patients inadequately controlled on timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide","volume":"106","author":"Clineschmidt","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.007_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/bjo.82.11.1249","article-title":"Comparison of the safety and efficacy of the fixed combination of dorzolamide\/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study","volume":"82","author":"Hutzelmann","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.007_bib7","first-page":"10","article-title":"A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol or dorzolamide","volume":"106","author":"Boyle","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.007_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1600-0420.2004.0205.x","article-title":"Efficacy and tolerability of the dorzolamide 2%\/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials","volume":"82","author":"Fechtner","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2007.03.007_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0161-6420(03)00404-4","article-title":"Twenty-four\u2013hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination","volume":"110","author":"Konstas","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.007_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archopht.121.4.453","article-title":"The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension","volume":"121","author":"Orzalesi","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.007_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archopht.1997.01100150184006","article-title":"Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma","volume":"115","author":"Konstas","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.007_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archopht.1997.01100160145002","article-title":"Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma","volume":"115","author":"Konstas","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.007_bib13","series-title":"Essentials of Statistics","author":"Book","year":"1978"},{"key":"10.1016\/j.ophtha.2007.03.007_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9394(99)00073-2","article-title":"Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma","volume":"128","author":"Konstas","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.007_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/jop.1998.14.129","article-title":"The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily","volume":"14","author":"Mundorf","year":"1998","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2007.03.007_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1755-3768.1987.tb07052.x","article-title":"A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure","volume":"65","author":"Duff","year":"1987","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.ophtha.2007.03.007_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0002-9394(00)00902-8","article-title":"The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension","volume":"131","author":"Stewart","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.007_bib18","first-page":"63","article-title":"Nonparametric Statistics for the Behavioral Sciences","author":"Siegel","year":"1956"},{"key":"10.1016\/j.ophtha.2007.03.007_bib19","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1167\/iovs.02-1281","article-title":"Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide","volume":"44","author":"Richter","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2007.03.007_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.007_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1034\/j.1600-0420.2003.00070.x","article-title":"Measuring visual field progression in the Early Manifest Glaucoma Trial","volume":"81","author":"Heijl","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2007.03.007_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0039-6257(83)90138-8","article-title":"Shortterm \u201cescape\u201d and longterm \u201cdrift\u201d: the dissipation effects of the beta adrenergic blocking agents","volume":"28","author":"Boger","year":"1983","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.007_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00417-004-0866-2","article-title":"A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients","volume":"242","author":"Manni","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.007_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/108076803322472971","article-title":"Intraocular pressure, safety, and quality of life in glaucoma patients switching to latanoprost from monotherapy treatments","volume":"19","author":"Zimmerman","year":"2003","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007002321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007002321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:53:15Z","timestamp":1758981195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642007002321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0161642007002321"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.007","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the 24-Hour Intraocular Pressure\u2013Lowering Effects of Latanoprost and Dorzolamide\/Timolol Fixed Combination after 2 and 6 Months of Treatment","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}